Characteristics | |
---|---|
Age at diagnosis of SLE, yrs, median (range) | 30 (16–57) |
Sex ratio, M/F | 1/8.6 |
Ethnicity | |
White | 16 (55.2) |
Black | 8 (27.6) |
Asian | 5 (17.2) |
Inaugural LM | 17/29 (58.6) |
SLEDAI (LM) median (range) | 8 (4–21) |
APS | 5/12 |
SLE before LM | 12/29 |
Median followup SLE-LM, mos (range) | 120 (2–276) |
Treatments when myocarditis occurred (among the 12 patients with previously diagnosed SLE*) | |
Hydroxychloroquine | 5/11 |
Prednisone | 5/11 |
Mycophenolate mofetil | 1/11 |
Azathioprine | 2/11 |
Methotrexate | 1/11 |
No treatment | 5/11 |
Hemodialysis | 1/12 |
Symptoms | n** (%) |
Dyspnea | 20/27 (74) |
Fever | 17/27 (63) |
Chest pain | 11/27 (41) |
Orthopnea | 10/27 (37) |
Palpitations | 4/27 (15) |
Signs | |
Lung rales | 15/27 (55) |
Lower limb edema | 6/27 (22) |
New cardiac murmur | 5/27 (18) |
Jugular venous distention | 3/27 (11) |
Hepatomegaly | 3/27 (11) |
Liver pain† | 2/27 (7) |
↵* Missing data, n = 1.
↵** Missing data, n = 2.
↵† Right upper abdominal pain referring to right cardiac failure. LM: lupus myocarditis; APS: antiphospholipid syndrome; SLE: systemic lupus erythematosus; SLE-LM: median time between diagnosis of SLE and diagnosis of LM; SLEDAI: SLE Disease Activity Index.